Christopher P Leamon - Net Worth and Insider Trading
Christopher P Leamon Net Worth
The estimated net worth of Christopher P Leamon is at least $3 Million dollars as of 2024-05-08. Christopher P Leamon is the Vice President of Research of Endocyte Inc and owns about 121,353 shares of Endocyte Inc (ECYT) stock worth over $3 Million. Details can be seen in Christopher P Leamon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher P Leamon has not made any transactions after 2018-10-05 and currently still holds the listed stock(s).
Transaction Summary of Christopher P Leamon
Christopher P Leamon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P Leamon owns 1 companies in total, including Fusion Pharmaceuticals Inc (FUSN) .
Click here to see the complete history of Christopher P Leamon’s form 4 insider trades.
Insider Ownership Summary of Christopher P Leamon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2021-11-01 | Chief Scientific Officer |
Christopher P Leamon Latest Holdings Summary
Christopher P Leamon currently owns a total of 1 stock. Christopher P Leamon owns 121,353 shares of Endocyte Inc (ECYT) as of October 5, 2018, with a value of $3 Million.
Latest Holdings of Christopher P Leamon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2018-10-05 | 121,353 | 23.99 | 2,911,258 |
Holding Weightings of Christopher P Leamon
Christopher P Leamon Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P Leamon has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 9,028 shares on October 5, 2018, which brought Christopher P Leamon around $140,476.
Insider Trading History of Christopher P Leamon
- 1
Christopher P Leamon Trading Performance
GuruFocus tracks the stock performance after each of Christopher P Leamon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P Leamon is 68.05%. GuruFocus also compares Christopher P Leamon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P Leamon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher P Leamon's insider trading performs compared to the benchmark.
Performance of Christopher P Leamon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.18 | | | | | |
| Relative Return to S&P 500(%) | 5.42 | | | | | |
Christopher P Leamon Ownership Network
Christopher P Leamon Owned Company Details
What does Fusion Pharmaceuticals Inc do?
Who are the key executives at Fusion Pharmaceuticals Inc?
Christopher P Leamon is the Chief Scientific Officer of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include Chief Medical Officer Dmitri Bobilev , director & Chief Executive Officer John Valliant , and President and CBO Mohit Rawat .
Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fusion Pharmaceuticals Inc Insider Transactions
Christopher P Leamon Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P Leamon. You might contact Christopher P Leamon via mailing address: C/o Fusion Pharmaceuticals Inc., 2 International Place Suite 2310, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
